Pathobiology of cardiac dyssynchrony and resynchronization

Heart Rhythm

Volumn 6, Issue 11, 2009, Pages 1660-1665

  Kass, David A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Animal model; Apoptosis; Beta adrenergic receptor; Calcium; Cardiac resynchronization therapy; Dyssynchrony; Excitation contraction coupling; Heart failure; Ion channel; Molecular biology; Myocyte; Stress response kinase

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CALCIUM ION; TUMOR NECROSIS FACTOR ALPHA;

ACTION POTENTIAL; ARTICLE; BETA ADRENERGIC STIMULATION; CARDIAC DYSSYNCHRONY; CARDIAC RESYNCHRONIZATION THERAPY; CELL SURVIVAL; EXPERIMENTAL MODEL; GLOBAL CHANGE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART STROKE VOLUME; HUMAN; LONG TERM CARE; NONHUMAN; PATHOLOGY; POLARIZATION; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; CARDIAC PACING, ARTIFICIAL; DISEASE MODELS, ANIMAL; HEART FAILURE; HUMANS; MUSCLE CELLS; PACEMAKER, ARTIFICIAL;

EID: 70350488085     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.08.017     Document Type: Article

References (33)

1. Rodeheffer R.J. The new epidemiology of heart failure. Curr Cardiol Rep 5 (2003) 181-186
2. Tsuyuki R.T., Shibata M.C., Nilsson C., and Hervas-Malo M. Contemporary burden of illness of congestive heart failure in Canada. Can J Cardiol 19 (2003) 436-438
3. Masoudi F.A., Havranek E.P., and Krumholz H.M. The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research. Heart Fail Rev 7 (2002) 9-16
4. Iuliano S., Fisher S.G., Karasik P.E., Fletcher R.D., and Singh S.N. QRS duration and mortality in patients with congestive heart failure. Am Heart J 143 (2002) 1085-1091
5. Kashani A., and Barold S.S. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 46 (2005) 2183-2192
6. Bader H., Garrigue S., Lafitte S., et al. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 43 (2004) 248-256
7. Cho G.Y., Song J.K., Park W.J., et al. Mechanical dyssynchrony assessed by tissue Doppler imaging is a powerful predictor of mortality in congestive heart failure with normal QRS duration. J Am Coll Cardiol 46 (2005) 2237-2243
8. Prinzen F.W., Hunter W.C., Wyman B.T., and McVeigh E.R. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 33 (1999) 1735-1742
9. Owen C.H., Esposito D.J., Davis J.W., and Glower D.D. The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs. Pacing Clin Electrophysiol 21 (1998) 1417-1429
10. Chalil S., Stegemann B., Muhyaldeen S., et al. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol 50 (2007) 243-252
11. Yu C.M., Lin H., Zhang Q., and Sanderson J.E. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 89 (2003) 54-60
12. Kass D.A., Chen C.H., Curry C., et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 99 (1999) 1567-1573
13. Nelson G.S., Berger R.D., Fetics B.J., et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 102 (2000) 3053-3059
14. Nowak B., Sinha A.M., Schaefer W.M., et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 41 (2003) 1523-1528
15. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
16. Cleland J.G., Daubert J.C., Erdmann E., et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure. [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 27 (2006) 1928-1932
17. Abraham W.T. Cardiac resynchronization therapy. Prog Cardiovasc Dis 48 (2006) 232-238
18. Chung E.S., Leon A.R., Tavazzi L., et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 117 (2008) 2608-2616
19. Bleeker G.B., Mollema S.A., olman E.R., et al. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy. Circulation 116 (2007) 1140-1148
20. Spragg D.D., Leclercq C., Loghmani M., et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 108 (2003) 929-932
21. Chakir K., Daya S.K., Tunin R.S., et al. Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 117 (2008) 1369-1377
22. Barth A.S., Aiba T., Halperin V., et al. Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circ Cardiovasc Gen 2 (2009) 371-378
23. Vanderheyden M., Mullens W., Delrue L., et al. Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy. J Card Fail 14 (2008) 172-178
24. Vanderheyden M., Mullens W., Delrue L., et al. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol 51 (2008) 129-136
25. Mullens W., Bartunek J., Wilson Tang W.H., et al. Early and late effects of cardiac resynchronization therapy on force-frequency relation and contractility regulating gene expression in heart failure patients. Heart Rhythm 5 (2008) 52-59
26. Nishijima Y., Sridhar A., Viatchenko-Karpinski S., et al. Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy. Life Sci 81 (2007) 1152-1159
27. Aiba T., Hasketh G.G., Barth A.S., et al. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 119 (2009) 1220-1230
28. Agnetti G., Kaludercic N., Kane L.A., et al. Modulation of mitochondrial proteome and improved mitochondrial function by bi-ventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Gen (2009) (In press)
29. Chakir K., Daya S.K., Aiba T., et al. Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy. Circulation 119 (2009) 1231-1240
30. Liggett S.B., Cresci S., Kelly R.J., et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med 14 (2008) 510-517
31. Mialet P.J., Rathz D.A., Petrashevskaya N.N., et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 9 (2003) 1300-1305
32. Kass D.A. Highlighting the R in CRT. Circulation 116 (2007) 1434-1436
33. Klotz S., Jan Danser A.H., and Burkhoff D. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodelling process. Prog Biophys Mol Biol 97 (2008) 479-496 (Review)